Stockscreener 앱 받기
44.03
3.49%
-1.59
시장 영업 전:
43.88
-0.15
-0.34%
전일 마감가:
$45.62
열려 있는:
$46.18
하루 거래량:
1.34M
Relative Volume:
1.10
시가총액:
$3.52B
수익:
-
순이익/손실:
$-269.44M
주가수익비율:
-11.74
EPS:
-3.75
순현금흐름:
$-262.63M
1주 성능:
-6.20%
1개월 성능:
-9.44%
6개월 성능:
-1.12%
1년 성능:
+67.41%
1일 변동 폭
$43.08
$46.18
1주일 범위
$43.08
$47.67
52주 변동 폭
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
44.03 | 3.63B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-04 | 개시 | TD Cowen | Buy |
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Propel Bio Management LLC Reduces Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. $AKRO Holdings Lowered by Alkeon Capital Management LLC - MarketBeat
ADAR1 Capital Management LLC Has $2.88 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Redmile Group LLC Sells 295,932 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Baker BROS. Advisors LP Trims Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Should you wait for a breakout in Akero Therapeutics Inc.Market Volume Report & Advanced Swing Trade Entry Plans - Newser
Best data tools to analyze Akero Therapeutics Inc. stockMarket Volume Report & Advanced Swing Trade Entry Plans - Newser
Will Akero Therapeutics Inc. continue its uptrendJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Chart based exit strategy for Akero Therapeutics Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser
7,221 Shares in Akero Therapeutics, Inc. $AKRO Acquired by HighTower Advisors LLC - MarketBeat
Can Akero Therapeutics Inc. disrupt its industryTrade Risk Summary & Risk Controlled Stock Alerts - khodrobank.com
Risk vs reward if holding onto Akero Therapeutics Inc.2025 Market Overview & Fast Moving Trade Plans - Newser
Northern Trust Corp Has $26.59 Million Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat
How to build a dashboard for Akero Therapeutics Inc. stockWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
16,473 Shares in Akero Therapeutics, Inc. $AKRO Acquired by FORA Capital LLC - MarketBeat
Historical volatility pattern of Akero Therapeutics Inc. visualized2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Akero Therapeutics Inc.July 2025 Intraday Action & Accurate Trade Setup Notifications - Newser
How to interpret RSI for Akero Therapeutics Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
Akero Therapeutics, Inc. $AKRO Position Trimmed by Tema Etfs LLC - MarketBeat
How to escape a deep drawdown in Akero Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - Newser
Akero Therapeutics Inc. stock daily chart insightsBear Alert & Real-Time Volume Surge Alerts - Newser
Key resistance and support levels for Akero Therapeutics Inc.Weekly Investment Summary & AI Optimized Trade Strategies - Newser
Published on: 2025-09-03 20:48:57 - beatles.ru
Akero Therapeutics Inc. recovery potential after sell off2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Using flow based indicators on Akero Therapeutics Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser
Can Akero Therapeutics Inc. deliver alphaJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - khodrobank.com
Intraday pattern recognizer results for Akero Therapeutics Inc.Rate Hike & AI Enhanced Trading Alerts - Newser
Walleye Capital LLC Decreases Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Buy" by Analysts - MarketBeat
Published on: 2025-09-03 02:35:46 - Newser
Chart overlay techniques for tracking Akero Therapeutics Inc.Quarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Akero Therapeutics, Inc. $AKRO Shares Purchased by Long Focus Capital Management LLC - MarketBeat
Market reaction to Akero Therapeutics Inc.’s recent newsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser
What MACD and RSI say about Akero Therapeutics Inc.Weekly Trade Summary & Growth Oriented Trading Recommendations - Newser
How cyclical is Akero Therapeutics Inc.’s revenue streamVolume Spike & Free Technical Pattern Based Buy Signals - khodrobank.com
Is Akero Therapeutics Inc. forming a reversal pattern2025 Support & Resistance & Fast Gain Swing Alerts - Newser
Will Akero Therapeutics Inc. price bounce be sustainable2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
How does Akero Therapeutics Inc. compare to its peersJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - khodrobank.com
Exit strategy if you’re trapped in Akero Therapeutics Inc.Quarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Akero Therapeutics, Inc. $AKRO Shares Acquired by Invesco Ltd. - MarketBeat
How does Akero Therapeutics Inc. score in quality rankingsProfit Target & Expert Approved Momentum Trade Ideas - khodrobank.com
Smart tools for monitoring Akero Therapeutics Inc.’s price action2025 Geopolitical Influence & Growth Focused Entry Reports - Newser
Can Akero Therapeutics Inc. rally from current levelsTrade Signal Summary & Long-Term Safe Investment Plans - Newser
Candlestick signals on Akero Therapeutics Inc. stock today2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Aug Gainers: What’s Akero Therapeutics Inc.’s historical returnQuarterly Investment Review & Low Risk High Win Rate Stock Picks - khodrobank.com
Candlestick Reversal Detected on Akero Therapeutics Inc.’s ChartLayoff News & Accurate Technical Buy Alerts - beatles.ru
What’s Akero Therapeutics Inc.’s historical returnPortfolio Gains Report & Weekly Hot Stock Watchlists - khodrobank.com
Aug Rallies: Will Akero Therapeutics Inc. benefit from rising consumer demandTrade Exit Report & Low Risk Entry Point Tips - khodrobank.com
Akero Therapeutics Inc. Stages Intraday Comeback — Trend ChangeQuarterly Trade Report & Low Risk High Reward Ideas - beatles.ru
Will Akero Therapeutics Inc. benefit from rising consumer demand2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Akero Therapeutics Inc 주식 (AKRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Young Jonathan | Chief Operating Officer |
Aug 12 '25 |
Option Exercise |
21.10 |
12,500 |
263,750 |
209,984 |
| Young Jonathan | Chief Operating Officer |
Aug 12 '25 |
Sale |
47.79 |
12,500 |
597,326 |
197,484 |
| Cheng Andrew | President and CEO |
Aug 11 '25 |
Sale |
48.59 |
30,000 |
1,457,596 |
490,757 |
| Henderson Jane | Director |
Aug 12 '25 |
Option Exercise |
7.01 |
3,000 |
21,027 |
12,398 |
| Henderson Jane | Director |
Aug 12 '25 |
Sale |
47.46 |
3,000 |
142,371 |
9,398 |
1.75%
1.11%
자본화:
|
볼륨(24시간):